SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis
Europe - FRA:SHL - DE000SHL1006 - Common Stock
47.63 EUR
-0.18 (-0.38%)
We assign a fundamental rating of 5 out of 10 to SHL. SHL was compared to 59 industry peers in the Health Care Equipment & Supplies industry. While SHL is still in line with the averages on profitability rating, there are concerns on its financial health. SHL is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
SHL had positive earnings in the past year.
SHL had a positive operating cash flow in the past year.
SHL had positive earnings in each of the past 5 years.
SHL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 4.87%, SHL is in the better half of the industry, outperforming 69.49% of the companies in the same industry.
The Return On Equity of SHL (12.29%) is better than 76.27% of its industry peers.
The Return On Invested Capital of SHL (7.89%) is better than 72.88% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SHL is below the industry average of 8.90%.
The 3 year average ROIC (5.87%) for SHL is below the current ROIC(7.89%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.87% | ||
| ROE | 12.29% | ||
| ROIC | 7.89% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
1.3 Margins
The Profit Margin of SHL (9.29%) is better than 72.88% of its industry peers.
SHL's Profit Margin has declined in the last couple of years.
SHL's Operating Margin of 13.76% is fine compared to the rest of the industry. SHL outperforms 71.19% of its industry peers.
In the last couple of years the Operating Margin of SHL has declined.
With a Gross Margin value of 38.76%, SHL is not doing good in the industry: 74.58% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of SHL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.76% | ||
| PM (TTM) | 9.29% | ||
| GM | 38.76% |
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
2. Health
2.1 Basic Checks
SHL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
SHL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SHL has been increased compared to 5 years ago.
Compared to 1 year ago, SHL has an improved debt to assets ratio.
2.2 Solvency
SHL has an Altman-Z score of 2.09. This is not the best score and indicates that SHL is in the grey zone with still only limited risk for bankruptcy at the moment.
SHL has a Altman-Z score (2.09) which is in line with its industry peers.
The Debt to FCF ratio of SHL is 5.10, which is a neutral value as it means it would take SHL, 5.10 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of SHL (5.10) is better than 61.02% of its industry peers.
A Debt/Equity ratio of 0.66 indicates that SHL is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.66, SHL is doing worse than 67.80% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 5.1 | ||
| Altman-Z | 2.09 |
ROIC/WACC1.32
WACC5.98%
2.3 Liquidity
SHL has a Current Ratio of 1.12. This is a normal value and indicates that SHL is financially healthy and should not expect problems in meeting its short term obligations.
SHL has a Current ratio of 1.12. This is in the lower half of the industry: SHL underperforms 72.88% of its industry peers.
SHL has a Quick Ratio of 1.12. This is a bad value and indicates that SHL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.77, SHL is not doing good in the industry: 71.19% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.77 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 11.21% over the past year.
The Earnings Per Share has been growing slightly by 7.27% on average over the past years.
SHL shows a small growth in Revenue. In the last year, the Revenue has grown by 5.85%.
The Revenue has been growing by 9.02% on average over the past years. This is quite good.
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
3.2 Future
Based on estimates for the next years, SHL will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.80% on average per year.
SHL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.17% yearly.
EPS Next Y9.58%
EPS Next 2Y8.35%
EPS Next 3Y9.57%
EPS Next 5Y9.8%
Revenue Next Year4.94%
Revenue Next 2Y4.73%
Revenue Next 3Y5.15%
Revenue Next 5Y5.17%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 20.01, SHL is valued on the expensive side.
Based on the Price/Earnings ratio, SHL is valued cheaply inside the industry as 81.36% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.20. SHL is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 18.19 indicates a rather expensive valuation of SHL.
72.88% of the companies in the same industry are more expensive than SHL, based on the Price/Forward Earnings ratio.
SHL is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.71, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.01 | ||
| Fwd PE | 18.19 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SHL is valued a bit cheaper than 64.41% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SHL indicates a rather cheap valuation: SHL is cheaper than 86.44% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.47 | ||
| EV/EBITDA | 14.72 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SHL does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of SHL may justify a higher PE ratio.
PEG (NY)2.09
PEG (5Y)2.75
EPS Next 2Y8.35%
EPS Next 3Y9.57%
5. Dividend
5.1 Amount
SHL has a Yearly Dividend Yield of 1.98%.
Compared to an average industry Dividend Yield of 2.30, SHL pays a bit more dividend than its industry peers.
SHL's Dividend Yield is comparable with the S&P500 average which is at 2.38.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.98% |
5.2 History
The dividend of SHL is nicely growing with an annual growth rate of 6.35%!
Dividend Growth(5Y)6.35%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
49.08% of the earnings are spent on dividend by SHL. This is a bit on the high side, but may be sustainable.
The dividend of SHL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.08%
EPS Next 2Y8.35%
EPS Next 3Y9.57%
FRA:SHL (9/16/2025, 7:00:00 PM)
47.63
-0.18 (-0.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners10.84%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap53.73B
Analysts83.7
Price Target61.88 (29.92%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.98% |
Yearly Dividend0.95
Dividend Growth(5Y)6.35%
DP49.08%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.66%
Min EPS beat(2)-2.04%
Max EPS beat(2)13.36%
EPS beat(4)3
Avg EPS beat(4)5.82%
Min EPS beat(4)-2.04%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)3.25%
EPS beat(12)8
Avg EPS beat(12)3.67%
EPS beat(16)10
Avg EPS beat(16)2.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.25%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)0.27%
Revenue beat(4)2
Avg Revenue beat(4)-0.01%
Min Revenue beat(4)-0.81%
Max Revenue beat(4)1.29%
Revenue beat(8)3
Avg Revenue beat(8)-0.4%
Revenue beat(12)4
Avg Revenue beat(12)-0.45%
Revenue beat(16)8
Avg Revenue beat(16)0.12%
PT rev (1m)0.24%
PT rev (3m)-0.79%
EPS NQ rev (1m)-2.8%
EPS NQ rev (3m)-16.03%
EPS NY rev (1m)-2.35%
EPS NY rev (3m)-2.35%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)-4.82%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-0.71%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.01 | ||
| Fwd PE | 18.19 | ||
| P/S | 2.3 | ||
| P/FCF | 17.47 | ||
| P/OCF | 13.97 | ||
| P/B | 3.04 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.72 |
EPS(TTM)2.38
EY5%
EPS(NY)2.62
Fwd EY5.5%
FCF(TTM)2.73
FCFY5.73%
OCF(TTM)3.41
OCFY7.16%
SpS20.73
BVpS15.67
TBVpS-5.42
PEG (NY)2.09
PEG (5Y)2.75
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.87% | ||
| ROE | 12.29% | ||
| ROCE | 10.07% | ||
| ROIC | 7.89% | ||
| ROICexc | 8.64% | ||
| ROICexgc | 46.76% | ||
| OM | 13.76% | ||
| PM (TTM) | 9.29% | ||
| GM | 38.76% | ||
| FCFM | 13.16% |
ROA(3y)3.87%
ROA(5y)4.27%
ROE(3y)9.76%
ROE(5y)10.27%
ROIC(3y)5.87%
ROIC(5y)6.49%
ROICexc(3y)6.25%
ROICexc(5y)6.86%
ROICexgc(3y)30.57%
ROICexgc(5y)31.67%
ROCE(3y)7.49%
ROCE(5y)8.29%
ROICexcg growth 3Y-8.79%
ROICexcg growth 5Y-3.88%
ROICexc growth 3Y1.69%
ROICexc growth 5Y-10.54%
OM growth 3Y-4.02%
OM growth 5Y-4.5%
PM growth 3Y-3.26%
PM growth 5Y-4.26%
GM growth 3Y-0.66%
GM growth 5Y-1.05%
F-Score8
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 5.1 | ||
| Debt/EBITDA | 2.58 | ||
| Cap/Depr | 59.37% | ||
| Cap/Sales | 3.29% | ||
| Interest Coverage | 7.09 | ||
| Cash Conversion | 85.2% | ||
| Profit Quality | 141.62% | ||
| Current Ratio | 1.12 | ||
| Quick Ratio | 0.77 | ||
| Altman-Z | 2.09 |
F-Score8
WACC5.98%
ROIC/WACC1.32
Cap/Depr(3y)58.06%
Cap/Depr(5y)61.48%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3.7%
Profit Quality(3y)91.88%
Profit Quality(5y)100.74%
High Growth Momentum
Growth
EPS 1Y (TTM)11.21%
EPS 3Y3.35%
EPS 5Y7.27%
EPS Q2Q%23.08%
EPS Next Y9.58%
EPS Next 2Y8.35%
EPS Next 3Y9.57%
EPS Next 5Y9.8%
Revenue 1Y (TTM)5.85%
Revenue growth 3Y7.51%
Revenue growth 5Y9.02%
Sales Q2Q%4.41%
Revenue Next Year4.94%
Revenue Next 2Y4.73%
Revenue Next 3Y5.15%
Revenue Next 5Y5.17%
EBIT growth 1Y18.19%
EBIT growth 3Y3.18%
EBIT growth 5Y4.12%
EBIT Next Year49.6%
EBIT Next 3Y21.79%
EBIT Next 5Y15.45%
FCF growth 1Y161.12%
FCF growth 3Y-1.94%
FCF growth 5Y15.48%
OCF growth 1Y86.79%
OCF growth 3Y-1.23%
OCF growth 5Y11.83%